Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ZYDUS LIFESCIENCES vs TORRENT PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ZYDUS LIFESCIENCES TORRENT PHARMA ZYDUS LIFESCIENCES/
TORRENT PHARMA
 
P/E (TTM) x 34.2 58.9 58.1% View Chart
P/BV x 5.8 14.2 40.7% View Chart
Dividend Yield % 0.6 0.8 70.6%  

Financials

 ZYDUS LIFESCIENCES   TORRENT PHARMA
EQUITY SHARE DATA
    ZYDUS LIFESCIENCES
Mar-23
TORRENT PHARMA
Mar-23
ZYDUS LIFESCIENCES/
TORRENT PHARMA
5-Yr Chart
Click to enlarge
High Rs4951,723 28.7%   
Low Rs3191,243 25.7%   
Sales per share (Unadj.) Rs170.3284.2 59.9%  
Earnings per share (Unadj.) Rs19.836.8 53.8%  
Cash flow per share (Unadj.) Rs26.957.7 46.7%  
Dividends per share (Unadj.) Rs6.0022.00 27.3%  
Avg Dividend yield %1.51.5 99.3%  
Book value per share (Unadj.) Rs173.0183.1 94.5%  
Shares outstanding (eoy) m1,012.20338.45 299.1%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.45.2 45.8%   
Avg P/E ratio x20.640.3 51.1%  
P/CF ratio (eoy) x15.125.7 58.8%  
Price / Book Value ratio x2.48.1 29.1%  
Dividend payout %30.359.8 50.7%   
Avg Mkt Cap Rs m412,144501,779 82.1%   
No. of employees `000NANA-   
Total wages/salary Rs m24,56416,777 146.4%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m172,37496,202 179.2%  
Other income Rs m4,746632 750.7%   
Total revenues Rs m177,12096,834 182.9%   
Gross profit Rs m29,67728,240 105.1%  
Depreciation Rs m7,2277,066 102.3%   
Interest Rs m1,2993,334 39.0%   
Profit before tax Rs m25,89718,472 140.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m5,8786,019 97.7%   
Profit after tax Rs m20,01912,452 160.8%  
Gross profit margin %17.229.4 58.7%  
Effective tax rate %22.732.6 69.7%   
Net profit margin %11.612.9 89.7%  
BALANCE SHEET DATA
Current assets Rs m100,08253,137 188.3%   
Current liabilities Rs m55,26754,473 101.5%   
Net working cap to sales %26.0-1.4 -1,872.4%  
Current ratio x1.81.0 185.6%  
Inventory Days Days5015 324.7%  
Debtors Days Days947 1,268.1%  
Net fixed assets Rs m144,77691,390 158.4%   
Share capital Rs m1,0121,692 59.8%   
"Free" reserves Rs m174,14660,288 288.9%   
Net worth Rs m175,15861,981 282.6%   
Long term debt Rs m024,962 0.0%   
Total assets Rs m244,940144,682 169.3%  
Interest coverage x20.96.5 320.1%   
Debt to equity ratio x00.4 0.0%  
Sales to assets ratio x0.70.7 105.8%   
Return on assets %8.710.9 79.8%  
Return on equity %11.420.1 56.9%  
Return on capital %15.525.1 61.9%  
Exports to sales %39.221.8 179.6%   
Imports to sales %11.90-   
Exports (fob) Rs m67,57720,994 321.9%   
Imports (cif) Rs m20,544NA-   
Fx inflow Rs m67,57720,994 321.9%   
Fx outflow Rs m20,5443,735 550.0%   
Net fx Rs m47,03317,259 272.5%   
CASH FLOW
From Operations Rs m26,88823,681 113.5%  
From Investments Rs m11,712-24,153 -48.5%  
From Financial Activity Rs m-44,004774 -5,688.2%  
Net Cashflow Rs m-5,3381,101 -484.7%  

Share Holding

Indian Promoters % 75.0 71.3 105.2%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 18.0 21.3 84.6%  
FIIs % 5.0 14.1 35.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.0 28.8 87.0%  
Shareholders   306,495 69,117 443.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ZYDUS LIFESCIENCES With:   SUN PHARMA    DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    MANKIND PHARMA    


More on Cadila Healthcare vs Torrent Pharma

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Cadila Healthcare vs Torrent Pharma Share Price Performance

Period Cadila Healthcare Torrent Pharma S&P BSE HEALTHCARE
1-Day 0.57% 1.45% 1.18%
1-Month 7.77% -0.30% -0.75%
1-Year 107.52% 68.52% 61.82%
3-Year CAGR 32.30% 27.16% 18.16%
5-Year CAGR 24.52% 21.87% 19.79%

* Compound Annual Growth Rate

Here are more details on the Cadila Healthcare share price and the Torrent Pharma share price.

Moving on to shareholding structures...

The promoters of Cadila Healthcare hold a 75.0% stake in the company. In case of Torrent Pharma the stake stands at 71.3%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Cadila Healthcare and the shareholding pattern of Torrent Pharma.

Finally, a word on dividends...

In the most recent financial year, Cadila Healthcare paid a dividend of Rs 6.0 per share. This amounted to a Dividend Payout ratio of 30.3%.

Torrent Pharma paid Rs 22.0, and its dividend payout ratio stood at 59.8%.

You may visit here to review the dividend history of Cadila Healthcare, and the dividend history of Torrent Pharma.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.